AGP Executive Report
Last update: an hour agoAlzheimer’s Care Breakthrough: A first-of-its-kind LiBBY Phase II trial reported that a THC/CBD oral formulation significantly reduced agitation in hospice-eligible late-life dementia patients, with close to 90% showing improvement after 12 weeks, pushing cannabinoid options further into mainstream dementia conversations. Pet Safety: UK mountain rescue teams reported a Labrador rescued after suspected cannabis ingestion on Ben Nevis, highlighting rising pet poisoning cases as more households encounter cannabis. Public Health & Risk: A large U.S. study linked cannabis use disorder with nearly 4-times higher lung/bronchus cancer risk, adding pressure on regulators and clinicians to address heavy use harms. Policy Watch: Idaho’s medical cannabis ballot bid failed to qualify for November after missing signature thresholds, while Massachusetts certified a repeal initiative that would roll back adult-use sales and home cultivation. Industry Moves: Maryland’s social equity dispensaries are finally opening—only 17 of 83 licenses issued since 2023 are operating—while new product launches keep coming, including CBD-forward “daily wellness” chews and THC/CBD dementia-focused trial momentum. Enforcement: Nigeria’s customs and NDLEA seized over 4,100 kg of cannabis indica worth ₦26.5B hidden in vehicles at Apapa Port.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
